Descriptor English: | Mupirocin | ||||||
Descriptor Spanish: |
Mupirocina
| ||||||
Descriptor Portuguese: | Mupirocina | ||||||
Descriptor French: | Mupirocine | ||||||
Entry term(s): |
14C-Labeled Mupirocin BRL 4910A BRL-4910A BRL4910A Bactroban Mupirocin Calcium Mupirocin, 14C Labeled Mupirocin, 14C-Labeled Mupirocin, Calcium Salt (2:1) Mupirocin, Calcium Salt (2:1), Dihydrate Mupirocin, Lithium Salt Mupirocin, Sodium Salt Pseudomonic Acid Pseudomonic Acid A |
||||||
Tree number(s): |
D02.355.291.411.658 D03.383.663.555 D10.251.536 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016712 | ||||||
Scope note: | A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents Protein Synthesis Inhibitors |
||||||
Registry Number: | D0GX863OA5 | ||||||
CAS Type 1 Name: | Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))- | ||||||
Previous Indexing: |
Antibiotics (1966-1991) Fatty Acids (1966-1991) |
||||||
Public MeSH Note: | 1992; PSEUDOMONIC ACID was indexed under ANTIBIOTICS 1977-91 |
||||||
Online Note: | use MUPIROCIN (NM) to search PSEUDOMONIC ACID (NM) 1980-91 |
||||||
History Note: | 1992; was PSEUDOMONIC ACID (NM) 1977-91 |
||||||
DeCS ID: | 29953 | ||||||
Unique ID: | D016712 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1992/01/01 | ||||||
Date of Entry: | 1991/07/12 | ||||||
Revision Date: | 2018/05/21 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Lipids [D10]Lipids
|
Mupirocin
- Preferred
Mupirocin Calcium
- Narrower
Mupirocin, Sodium Salt
- Narrower
Mupirocin, Lithium Salt
- Narrower
BRL-4910A
- Narrower
Mupirocin, 14C-Labeled
- Narrower
Mupirocin, Calcium Salt (2:1)
- Narrower
Mupirocin, Calcium Salt (2:1), Dihydrate
- Narrower
Pseudomonic Acid
- Broader
Bactroban
- Narrower
Concept UI |
M0025454 |
Scope note | A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing. |
Preferred term | Mupirocin |
Entry term(s) |
Pseudomonic Acid A |
Concept UI |
M000642442 |
Preferred term | Mupirocin Calcium |
Concept UI |
M0329412 |
Preferred term | Mupirocin, Sodium Salt |
Concept UI |
M0329413 |
Preferred term | Mupirocin, Lithium Salt |
Concept UI |
M0353341 |
Preferred term | BRL-4910A |
Entry term(s) |
BRL 4910A BRL4910A |
Concept UI |
M0329414 |
Preferred term | Mupirocin, 14C-Labeled |
Entry term(s) |
14C-Labeled Mupirocin Mupirocin, 14C Labeled |
Concept UI |
M0329410 |
Preferred term | Mupirocin, Calcium Salt (2:1) |
Concept UI |
M0329411 |
Preferred term | Mupirocin, Calcium Salt (2:1), Dihydrate |
Concept UI |
M000642441 |
Preferred term | Pseudomonic Acid |
Concept UI |
M0353342 |
Preferred term | Bactroban |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey